Statutory Price Disclosure For Connecticut Prescribers

Notice to Connecticut Prescribers

This information is being provided pursuant to CT House Bill 6669. The information is accurate as of September 13, 2023. The prices listed are WAC prices, which represent Pfizer’s published list prices for the products sold to wholesalers, before any discount, rebate, or other price reduction. The WAC prices listed may differ significantly from actual prices paid by customers and consumers. In addition, a product’s WAC is typically not associated with per-dose pricing, and does not necessarily reflect price per dosage, price per course of treatment or the cost effectiveness of all the products listed. Pricing information listed does not imply safety or efficacy of the product, and no comparisons should be made.

More Information

For more information on the price disclosure requirements, please contact the Connecticut Department of Consumer Protection’s office:

Department of Consumer Protection 
450 Columbus Boulevard, Suite 901 
Hartford, Connecticut 06103-1840 
Ph. (860) 713-6100 / (860) 418-7001| Email: [email protected]

Marketed Products

• ABRYSVO™ (Respiratory Syncytial Virus Vaccine) solution for intramuscular injection (PDF)
• ADCETRIS® (brentuximab vedotin) intravenous injection (PDF)
• AMIDATE™ (etomidate) (PDF)
• ATGAM® (lymphocyte immune globulin, anti-thymocyte globulin [equine] sterile solution) (PDF)
• BAVENCIO® (avelumab) injection (PDF)
• BeneFIX® [coagulation factor IX (recombinant)] lyophilized powder for solution, for intravenous use (PDF)
• BESPONSA™ for injection (inotuzumab ozogamicin) (PDF)
• BICILLIN® C-R (penicillin G benzathine and penicillin G procaine injectable suspension) (PDF)
• BICILLIN® C-R 900/300 (penicillin G benzathine and penicillin G procaine injectable suspension) (PDF)
• BICILLIN® L-A (penicillin G benzathine) (PDF)
• BOSULIF® (bosutinib) tablets, for oral use (PDF)
• BRAFTOVI® (encorafenib) capsules (PDF)
• CAMPTOSAR® (irinotecan HCI injection) (PDF)
• CEREBYX® (fosphenytoin sodium injection) (PDF)
• CIBINQO® (abrocitinib) (PDF)
• CLEOCIN PHOSPHATE®(clindamycin injection, USP) and (clindamycin injection in 5% dextrose) (PDF)
• Cleocin T® (clindamycin phosphate topical solution, USP) (clindamycin phosphate topical gel (clindamycin phosphate topical lotion) (PDF)
• CORVERT® (ibutilide fumarate injection) (PDF)
• CUTAQUIG® (Immune Globulin Subcutaneous [Human] – hipp) (PDF)
• CYKLOKAPRON® (tranexamic acid injection) (PDF)
• DAURISMO™ (glasdegib) tablets, for oral use (PDF)
• DEMEROL™ (meperidine hydrochloride) (PDF)
• DEPO-MEDROL® (methylprednisolone acetate injectable suspension, USP) (PDF)
• DUAVEE® (conjugated estrogens/bazedoxifene) tablets (PDF)
• ELELYSO™  (taliglucerase alfa) (PDF)
• ELIQUIS® (apixaban) tablets for oral use (PDF)
• ELLENCE® (epirubicin hydrochloride injection) (PDF)
• ERAXIS™ (anidulafungin) (PDF)
• ELREXFIO™ (elranatamab-bcmm) injection, for subcutaneous use (PDF)
• ERYTHROCIN™ LACTOBIONATE (erythromycin lactobionate) (PDF)
• ESTRING® (estradiol vaginal ring) (PDF)
• EUCRISA™ (criasaborole) (PDF)
• FOSCAVIR® (foscarnet sodium) (PDF)
• FRAGMIN® (dalteparin sodium injection) (PDF)
• GEL-FLOW™ NT absorbable gelatin powder (PDF)
• GENOTROPIN® (somatropin) for injection, for subcutaneous use (PDF)
• HEMABATE® (carboprost tromethamine) (PDF)
• HEXTEND™ (hetastarch) (PDF)
• IBRANCE® (palbociclib) capsules, for oral use (PDF)
• Idamycin PFS® idarubicin hydrochloride injection (PDF)
• INFLECTRA® (infliximab-dyyb) (PDF)
• INLYTA® (axitinib) tablets for oral administration (PDF)
• LEVOPHED™  (norepinephrine) (PDF)
• LINCOCIN® (lincomycin) (PDF)
• LITFULO™ (ritlecitinib) capsules, for oral use (PDF)
• LORBRENA® (lorlatinib) tablets, for oral use (PDF)
• MARCAINE™ (bupivacaine hydrochloride) (PDF)
• MARCAINE® SPINAL (bupivacaine hydrochloride in dextrose injection) for subarachnoid injection (PDF)
• MARCAINE™ with Epinephrine 1:200,000 as the bitartrate (bupivacaine hydrochloride) (PDF)
• MEKTOVI® (binimetinib) tablets (PDF)
• MYLOTARG™ (gemtuzumab ozogamicin for injection) (PDF)
• NGENLA™ (somatrogon-ghla) injection, for subcutaneous use (PDF)
• NIPENT™ (pentostatin) (PDF)
• NIVESTYM™ (filgrastim-aafi) (PDF)
• NURTEC® ODT (rimegepant) orally disintegrating tablets (ODT), for sublingual or oral use (PDF)
• NYVEPRIA™ (pegfilgrastim-apgf) injection (PDF)
• OCTAGAM® 5% [Immune Globulin Intravenous (Human)] liquid (PDF)
• OCTAGAM® 10% [Immune Globulin Intravenous (Human)] liquid (PDF)
• PADCEV® (enfortumab vedotin-ejfv) intravenous injection (PDF)
• PANZYGA® (immune globulin intravenous, human - ifas) (PDF)
• PLEGISOL® (potassium chloride, sodium chloride, calcium chloride, and magnesium chloride) (PDF)
• PRECEDEX™ (dexmedetomidine hydrochloride) (PDF)
• PREMARIN® (conjugated estrogens) tablets, USP (PDF)
• PREPIDIL® (dinoprostone) (PDF)
• PREVNAR 20® (Pneumococcal 20-valent Conjugate Vaccine), suspension for intramuscular injection (PDF)
• PROSTIN VR PEDIATRIC® (alprostadil) (PDF)
• QUELICIN™ (succinylcholine chloride) (PDF)
• RETACRIT™ Injection (epoetin alfa-epbx) (PDF)
• RUXIENCE™ (rituximab-pvvr) injection, for intravenous use (PDF)
• SILVADENE® (silver sulfadiazine) (PDF)
• SOLU-CORTEF® (hydrocortisone sodium succinate) (PDF)
• SOLU-MEDROL® (methylprednisolone sodium succinate) (PDF)
• SOMAVERT®  (pegvisomant) (PDF)
• SUTENT® (sunitinib malate) capsules (PDF)
• TALZENNA™ (talazoparib) capsules (PDF)
• THROMBIN-JMI®  (thrombin, topical, bovine origin) (PDF)
• TICOVAC™ (Tick-Borne Encephalitis Vaccine), Suspension for intramuscular injection (PDF)
• TIVDAK® (tisotumab vedotin-tftv) intravenous injection (PDF)
• TOVIAZ™ (fesoterodine fumarate) extended-release capsules (PDF)
• TRUMENBA® (Meningococcal Group B Vaccine) Suspension for intramuscular injection (PDF)
• TRAZIMERA™ (trastuzumab-qyyp) for injection, for intravenous use (PDF)
• TUKYSA^® (tucatinib) Tablet (PDF)
• VIZIMPRO® tablets (dacomitinib) (PDF)
• VYNDAMAX™ (tafamidis) capsules (PDF)
• VYNDAQEL® (tafamidis meglumine) capsules (PDF)
• XALKORI® (crizotinib) capsules, oral (PDF)
• XELJANZ® (tofacitinib) tablets for oral administration (PDF)
• XTANDI® (enzalutamide) capsules, for oral use (PDF)
• XYNTHA® SOLOFUSE® (antihemophilic factor [recombinant]) lyophilized powder for solution in prefilled dual-chamber syringe, for intravenous injection (PDF)
• ZAVZPRET (zavegepant) nasal spray (PDF)
• ZIRABEV™ (bevacizumab-bvzr) injection, for intravenous use (PDF)
• ZYVOX ® (linezolid) tablets (PDF)